| Program Type | Live Presentation | Availability | April 6, 2011 - 11:00a.m. – 12:00p.m. (CST) | Description | Steven D. Dallas, PhD - Clostridium difficile has re-emerged as a significant healthcare-associated pathogen. The most common methods for detecting this pathogen involve assays for its two toxins A and B. Recent literature suggests that many of the C. difficile toxin kit-based detection method suffer from inadequate sensitivity. This program will briefly review the current state of C. difficile-associated disease, detection and treatment, and compare current detection methods with emerging molecular methods and the relative advantages and disadvantages of each. | FL Approved | Yes | CA Approved Through Provider | CA Approved Through PACE | Yes | No. of contact hours | 1 | How to enroll/participate | This is a live continuing education conference. Call 1-800-982-8868 to register, or visit the website at http://ims.uthscsa.edu/training/ce.aspx#top for registration. | Costs | $50 for first participant, $25 for each additional | PACE Provider | University of Texas Health Science Center | Contact Information |
7703 Floyd Curl Drive – MSC 7978 San Antonio, TX 78229-3900 1-800-928-8868 quintanas@uthscsa.edu http://ims.uthscsa.edu/training/ce.aspx#top |